Nagpur: In a moment of recognition of his contribution towards academicand education in diabetes, Dr Sunil Gupta was awarded the prestigious NCCD Oration at the 8th National Congress on Clinical Diabetes (NCCD) held in Kolkata.Dr Gupta delivered a compelling address on ‘Insulin Initiation and Titration in Hyperglycemia in Pregnancy (HIP): Indian Perspectives’, offering critical insights tailored to the unique clinical challenges faced in India.Dr Gupta has already delivered 24 national orations at different academic platforms, and this was his 25th oration award. He has done nationwide acclaimed work in insulin therapy in pregnancy diabetes. He dedicated his oration awards to Dr V Seshai of Chennai and Dr Samar Banerjee of Kolkata. His session was chaired by Dr Niladri Sarkar and Dr Asish Basu, who emphasised the importance of advancing research and clinical practices in maternal diabetes management. Dr Gupta’s oration was particularly timely, as India continues to grapple with rising rates of gestational diabetes and the complex dynamics of insulin management in diverse and resource-variable settings.Drawing on years of clinical experience and extensive research, Dr Gupta highlighted the need for earlier diagnosis, culturally sensitive patient education, and practical titration protocols that align with Indian healthcare realities. His lecture provided a comprehensive roadmap for clinicians, balancing evidence-based strategies with real-world applicability. He stressed the importance of individualised care, especially in a population with varying levels of awareness, access, and compliance.The audience, comprising endocrinologists, diabetologists, obstetricians, and primary care physicians, responded with resounding appreciation. Dr Gupta’s oration is expected to influence national guidelines and inspire further studies focused on improving maternal and fetal outcomes in HIP cases.The NCCDI 2025, hosted in Kolkata, continues to serve as a vital platform for knowledge exchange and policy shaping in the fight against diabetes, reinforcing India’s commitment to innovative and inclusive clinical care.
